SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension. (2023)

First Author: Walters R
Attributed to:  Mechanisms underlying the development of pulmonary arterial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/circulationaha.122.061940

PubMed Identifier: 37066790

Publication URI: http://europepmc.org/abstract/MED/37066790

Type: Journal Article/Review

Volume: 147

Parent Publication: Circulation

Issue: 21

ISSN: 0009-7322